SynthesisPloS one2013

New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons.

Partha Sardar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.